Overview of the Global Cardiac Markers Market 2016 - Research and Markets
DUBLIN, August 22, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Cardiac Markers" report to their offering.
Biomarkers are biological or biochemical molecules, or genetic changes, or other characteristics that can be measured, and that indicate or predict a condition, risk, or likely response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. With the incidence of cardiovascular disease increasing greatly, cardiac markers are in huge demand.
Physicians use cardiac markers (CK-MB, troponin I, troponin T, myoglobin, brain natriuretic peptide (BNP), proBNP, high sensitive C-reactive protein (hsCRP), and homocysteine) and cardiovascular biomarkers in two ways: acute care to diagnose a cardiac event in a hospital emergency room (acute care) or chronic care to evaluate the risk of a cardiovascular event occurring and to monitor patients with a cardiovascular disease. The traditional markers CK-MB, troponin and myoglobin - were used in acute care and tests such as cholesterol were used to evaluate risk.
Cardiac Markers reviews the progression of cardiac diagnostic technologies and notes some trends in test strategies as well, including cardiac risk, genetics and cardiovascular disease, acute myocardial infarction and acute coronary syndrome, heart failure, lipid disorders, and ACP coronary heart disease screening.
There are currently a number of companies developing or marketing cardiac markers and cardiovascular biomarkers.
Key Topics Covered:
ONE: EXECUTIVE SUMMARY
TWO: INTRODUCTION
Overview
Cardiac Risk
Genetics and Cardiovascular Disease
Acute Myocardial Infarction and Acute Coronary Syndrome
Heart Failure
Lipid Disorders
ACP Coronary Heart Disease Screening
THREE: MARKET ANALYSIS
FOUR: COMPANY PROFILES
Abbott Laboratories
ALPCO
ARUP Laboratories
Axis-Shield Diagnostics, Ltd. (An Alere Company)
Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
bioMérieux SA
CardioDx, Inc.
CardioGenics Holdings Inc.
Gamma Therapeutics, Inc.
Ortho-Clinical Diagnostics
Quest Diagnostics
Randox Laboratories Ltd.
RENESE UG
Roche
Tosoh Corporation
Tosoh Bioscience, Inc.
Recent Revenue History
For more information about this report visit http://www.researchandmarkets.com/research/ph3pwf/cardiac_markers
Related Topics: Biomarkers
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article